Prospective Clinical Trial Registration

[1]  L. Naldi,et al.  The Cochrane Skin Group: Preparing, Maintaining, and Disseminating Systematic Reviews of Clinical Interventions in Dermatology , 1998 .

[2]  E. Carter,et al.  A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis. , 2004, Journal of the American Academy of Dermatology.

[3]  Kamran Abbasi,et al.  Compulsory registration of clinical trials , 2004, BMJ : British Medical Journal.

[4]  H. Williams,et al.  Systematic review of treatments for atopic eczema. , 2000, Health technology assessment.

[5]  H. Williams,et al.  Randomized clinical trials for psoriasis 1977-2000: the EDEN survey. , 2003, The Journal of investigative dermatology.

[6]  T. Diepgen.  Long‐term treatment with cetirizine of infants with atopic dermatitis: A multi‐country, double‐blind, randomized, placebo‐controlled trial (the ETAC™ trial) over 18 months , 2002 .

[7]  H. Williams,et al.  Evening primrose oil for atopic dermatitis , 2003, BMJ : British Medical Journal.

[8]  Clinical trial registration: a statement from the International Committee of Medical Journal Editors , 2004, The Lancet.

[9]  M. Lebwohl,et al.  A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. , 2003, The New England journal of medicine.

[10]  R. Stern,et al.  An evaluation of method reporting and use in clinical trials in dermatology. , 1985, Archives of dermatology.

[11]  John Hoey,et al.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2004, JAMA.

[12]  B. Beermann,et al.  Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications , 2003, BMJ : British Medical Journal.

[13]  H. Williams,et al.  How well are randomized controlled trials reported in the dermatology literature? , 2000, Archives of dermatology.

[14]  A. Menter,et al.  Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. , 2003, JAMA.

[15]  R. Stern.  A promising step forward in psoriasis therapy. , 2003, Journal of the American Medical Association (JAMA).

[16]  In the dark: drug companies should be forced to publish all the results of clinical trials. , 2004, New scientist.